Ali Torkamani Selected Research

Ali Torkamani Research Topics

Disease

9	Neoplasms (Cancer) 01/2018 - 03/2008
3	Parkinson Disease (Parkinson's Disease) 11/2023 - 10/2022
3	Carcinogenesis 10/2009 - 03/2008
2	Inborn Genetic Diseases (Disease, Hereditary) 10/2022 - 03/2014
2	Brain Diseases (Brain Disorder) 12/2019 - 10/2014
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 10/2019 - 11/2017
2	Colorectal Neoplasms (Colorectal Cancer) 01/2018 - 09/2009
1	Genetic Risk Score 10/2023
1	Genetic Predisposition to Disease (Genetic Predisposition) 10/2023
1	Type 2 Diabetes Mellitus (MODY) 10/2022
1	Diabetic Nephropathies (Diabetic Nephropathy) 10/2022
1	Bicuspid Aortic Valve Disease 01/2022
1	von Hippel-Lindau Disease (von Hippel Lindau Disease) 01/2022
1	Multiple Myeloma 01/2022
1	Tinnitus 10/2021
1	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 01/2021
1	Ebola Hemorrhagic Fever 01/2021
1	Vesicular Stomatitis 01/2021
1	Atherosclerotic Plaque (Atheroma) 11/2020
1	Hemophilia A (Haemophilia) 01/2020
1	Hemorrhage 01/2020
1	Fibrosis (Cirrhosis) 02/2019
1	Muscle Hypotonia (Hypotonia) 12/2018
1	Gastroesophageal Reflux (GERD) 12/2018
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2018
1	Rare Diseases (Rare Disease) 08/2017
1	Sudden Death 08/2017
1	Myocardial Infarction 01/2017
1	Rupture 01/2017
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2017
1	Dyskinesias (Dyskinesia) 12/2015
1	Neurodevelopmental Disorders 10/2014
1	Intellectual Disability (Idiocy) 10/2014
1	Autistic Disorder (Autism) 10/2014
1	Familial Dyskinesia with Facial Myokymia 04/2014
1	Melanoma (Melanoma, Malignant) 05/2011
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 10/2010
1	Schizophrenia (Dementia Praecox) 04/2010
1	Breast Neoplasms (Breast Cancer) 09/2009
1	Glioblastoma (Glioblastoma Multiforme) 09/2009
1	Oncogene Addiction 02/2009
1	Neuroblastoma 10/2008
1	Acute Kidney Injury (Acute Renal Failure) 08/2005

Drug/Important Bio-Agent (IBA)

5	Phosphotransferases (Kinase)IBA 01/2010 - 10/2008
4	DNA (Deoxyribonucleic Acid)IBA 10/2023 - 03/2008
4	Biomarkers (Surrogate Marker)IBA 10/2022 - 01/2017
4	Protein Kinases (Protein Kinase)IBA 10/2009 - 03/2008
3	Circulating Tumor DNAIBA 01/2018 - 01/2017
2	NucleotidesIBA 01/2023 - 10/2014
2	Adenylyl Cyclases (Adenylyl Cyclase)IBA 12/2015 - 04/2014
2	Proteins (Proteins, Gene)FDA Link 02/2009 - 03/2008
1	Adenosine Monophosphate (AMP)IBA 11/2023
1	HDL CholesterolIBA 10/2023
1	EndocannabinoidsIBA 10/2022
1	nidogen (entactin)IBA 10/2022
1	Metalloproteases (Metalloproteinases)IBA 01/2022
1	Potassium Channels (Potassium Channel)IBA 10/2021
1	VaccinesIBA 01/2021
1	Glycoproteins (Glycoprotein)IBA 01/2021
1	LipidsIBA 01/2021
1	CholesterolIBA 11/2020
1	Peptides (Polypeptides)IBA 11/2020
1	Myosins (Myosin)IBA 01/2020
1	CoagulantsIBA 01/2020
1	Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)IBA 12/2019
1	RNA (Ribonucleic Acid)IBA 10/2019
1	Long Noncoding RNAIBA 02/2019
1	HydrogelsIBA 02/2019
1	Lactic Acid (Lactate)FDA LinkGeneric 12/2018
1	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 01/2018
1	Mitochondrial DNA (mtDNA)IBA 08/2017
1	Cell-Free Nucleic AcidsIBA 01/2017
1	CytokinesIBA 10/2010
1	Dopamine (Intropin)FDA LinkGeneric 04/2010
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2009
1	Transforming Growth Factor beta (TGF-beta)IBA 09/2009
1	Focal Adhesion Protein-Tyrosine KinasesIBA 09/2009
1	Anaplastic Lymphoma KinaseIBA 10/2008
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 10/2008

Therapy/Procedure

3	Therapeutics 01/2017 - 08/2009
1	Oral Administration 11/2020
1	Diet Therapy (Therapy, Diet) 11/2017
1	Particle Accelerators 05/2011
1	Continuous Renal Replacement Therapy 08/2005
1	Hemofiltration 08/2005